Advertisement
Screener

Korro Bio, Inc. (KRRO) Auditor

Korro Bio, Inc. Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-03-12: Fiscal year end 2025-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Boston, Massachusetts.
  • 2025-03-18: Fiscal year end 2024-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Boston, Massachusetts.
  • 2024-03-26: Fiscal year end 2023-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Boston, Massachusetts.
  • 2023-05-01: Fiscal year end 2022-12-31; Auditor RSM US LLP; PCAOB firm ID 49; Location Boston, Massachusetts, USA.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-03-122025-12-31Ernst & Young LLP42Boston, MassachusettsNo
2025-03-182024-12-31Ernst & Young LLP42Boston, MassachusettsNo
2024-03-262023-12-31Ernst & Young LLP42Boston, MassachusettsNo
2023-05-012022-12-31RSM US LLP49Boston, Massachusetts, USANo
2023-03-102022-12-31RSM US LLP49Boston, Massachusetts, USANo
2022-03-152021-12-31RSM US LLP49Boston, Massachusetts, USANo
2021-03-292020-12-31RSM US LLPBoston, MassachusettsNo
2020-03-262019-12-31RSM US LLPBoston, Massachusetts

Similar stocks

Stock NameCountryMarket CapPE Ratio
Atrium Therapeutics, Inc. (RNA)United States$0.140B
SPRUCE BIOSCIENCES, INC. (SPRB)United States$0.142B-2.89
Curanex Pharmaceuticals Inc (CURX)United States$0.138B
Corbus Pharmaceuticals Holdings, Inc. (CRBP)United States$0.144B-1.72
Annexon, Inc. (ANNX)United States$0.147B-4.22
TuHURA Biosciences, Inc./NV (HURA)United States$0.134B-4.88
Unicycive Therapeutics, Inc. (UNCY)United States$0.134B-3.70
NRX Pharmaceuticals, Inc. (NRXP)United States$0.131B-6.31
MEDICINOVA INC (MNOV)United States$0.130B-6.04
IMMUNIC, INC. (IMUX)United States$0.127B-1.88